Edition:
India

Cesca Therapeutics Inc (KOOL.OQ)

KOOL.OQ on NASDAQ Stock Exchange Capital Market

0.44USD
22 Jun 2018
Change (% chg)

$-0.03 (-6.58%)
Prev Close
$0.47
Open
$0.48
Day's High
$0.48
Day's Low
$0.43
Volume
194,658
Avg. Vol
86,706
52-wk High
$6.43
52-wk Low
$0.42

Latest Key Developments (Source: Significant Developments)

Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina For X-Series Products
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS ANNOUNCES EVALUATION AGREEMENT WITH THE UNIVERSITY OF NORTH CAROLINA LINEBERGER ADVANCED CELLULAR THERAPEUTICS FACILITY FOR X-SERIES™ PRODUCTS THAT PROVIDE AUTOMATED, CLOSED SYSTEM CELLULAR PROCESSING.CESCA THERAPEUTICS INC - CESCA WILL BE RESPONSIBLE FOR PROVIDING ITS X-SERIES PRODUCTS, ALONG WITH REQUIRED TRAINING AND SUPPORT.  Full Article

Cesca Therapeutics Announces First Evaluation Agreement With A Leading U.S. Academic Research Institution For X-Series Products
Tuesday, 17 Apr 2018 

April 17 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS ANNOUNCES FIRST EVALUATION AGREEMENT WITH A LEADING U.S. ACADEMIC RESEARCH INSTITUTION FOR X-SERIES™ PRODUCTS THAT PROVIDE AUTOMATED, CLOSED SYSTEM CELLULAR PROCESSING.CESCA THERAPEUTICS INC - CESCA WILL BE RESPONSIBLE FOR PROVIDING ITS X-SERIES PRODUCTS, ALONG WITH REQUIRED TRAINING AND SUPPORT.  Full Article

Cesca Subsidiary Expands Into CAR-T Related Contract Development And Manufacturing
Wednesday, 14 Mar 2018 

March 14 (Reuters) - Cesca Therapeutics Inc ::CESCA’S DEVICE SUBSIDIARY, THERMOGENESIS, EXPANDS INTO CAR-T RELATED CONTRACT DEVELOPMENT AND MANUFACTURING (CDMO) SERVICES.CESCA THERAPEUTICS - UNIT SIGNED LICENSE AGREEMENT WITH INCOCELL TIANJIN, A UNIT OF BOYALIFE GROUP.CESCA THERAPEUTICS - UNIT GRANTED INCOCELL LICENSE TO BUY, AT DISCOUNTED PRICE, CERTAIN DEVICES, CONSUMABLES, KITS IN CERTAIN ASIA PACIFIC COUNTRIES.CESCA THERAPEUTICS- TERRITORIES COVERED UNDER AGREEMENT ARE CHINA, JAPAN, SOUTH KOREA, TAIWAN, HONG KONG, MACAU, SINGAPORE, MALAYSIA, INDONESIA, INDIA.CESCA THERAPEUTICS INC - UNIT ENTITLED TO PERCENTAGE OF INCOCELL'S GROSS CONTRACT DEVELOPMENT REVENUES.  Full Article

Cesca Therapeutics Announces Pricing Of Public Offering
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF UP TO 900,000 SHARES OF COMMON STOCK.CESCA THERAPEUTICS INC - PRICED REGISTERED PUBLIC OFFERING AT $3.00 PER SHARE​.  Full Article

Cesca Therapeutics Announces Proposed Public Offering Of Common Stock
Wednesday, 29 Nov 2017 

Nov 28 (Reuters) - Cesca Therapeutics Inc ::CESCA THERAPEUTICS INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.  Full Article

Cesca Therapeutics reports quarterly loss per share $0.24
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - Cesca Therapeutics Inc ::Cesca Therapeutics announces financial results for the three months ended September 30, 2017 and provides corporate update.Quarterly loss per share $0.24.Quarterly revenue $3.1 million versus $3.8 million.  Full Article

Empery Asset Management LP reports 5.43 pct passive stake in Cesca Therapeutics
Tuesday, 16 Aug 2016 

Cesca Therapeutics Inc : Empery Asset Management, LP reports 5.43 pct passive stake in Cesca Therapeutics as of August 4, 2016 - SEC Filing Source - http://bit.ly/2bl8rAM Further company coverage: [KOOL.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Cesca Therapeutics announces pricing of $2.5 mln registered direct offering
Thursday, 4 Aug 2016 

Cesca Therapeutics Inc: Cesca Therapeutics announces pricing of $2.5 million registered direct offering .To purchase 600,000 shares of common stock at a purchase price per share of $4.10.  Full Article

BRIEF-Cesca Prices $5.5 Million Public Offering

* CESCA THERAPEUTICS INC - IS OFFERING UNITS AT A PRICE OF $0.60 PER UNIT.